Last update 20 Mar 2025

Diphtheria/tetanus/pertussis/hepatitis B virus infection vaccine(Center For Genetic Engineering And Biotechnology)

Overview

Basic Info

Drug Type
Combination vaccine, Prophylactic vaccine
Synonyms
Trivac HB
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Infectious DiseasesDigestive System DisordersRespiratory Diseases+ [1]
Active Indication
DiphtheriaHepatitis BTetanus+ [1]
Inactive Indication-
Originator Organization
Centro de Ingenieria Genetica y Biotecnologia
Active Organization
Heber Biotec SACentro de Ingenieria Genetica y Biotecnologia
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Cuba (31 Dec 2009),
DiphtheriaHepatitis BTetanus+ [1]
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Diphtheria/tetanus/pertussis/hepatitis B virus infection vaccine(Center For Genetic Engineering And Biotechnology)
JPRN-UMIN000001627
/ CompletedNot ApplicableIIT
Efficacy of addition of HB vaccine in patients with chronic hepatitis B who are still HBeAg-positive after one year of entecavir administration: a randomized controlled trial - Entecavir plus HB vaccine combination trial
100 Clinical Results associated with Diphtheria/tetanus/pertussis/hepatitis B virus infection vaccine(Center For Genetic Engineering And Biotechnology)
Login to view more data
100 Translational Medicine associated with Diphtheria/tetanus/pertussis/hepatitis B virus infection vaccine(Center For Genetic Engineering And Biotechnology)
Login to view more data
100 Patents (Medical) associated with Diphtheria/tetanus/pertussis/hepatitis B virus infection vaccine(Center For Genetic Engineering And Biotechnology)
Login to view more data
100 Deals associated with Diphtheria/tetanus/pertussis/hepatitis B virus infection vaccine(Center For Genetic Engineering And Biotechnology)
Login to view more data

External Link

KEGGWikiATCDrug Bank
--
J07CA05
-

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diphtheria
Cuba
Centro de Ingenieria Genetica y Biotecnologia
31 Dec 2009
Hepatitis B
Cuba
Centro de Ingenieria Genetica y Biotecnologia
31 Dec 2009
Tetanus
Cuba
Centro de Ingenieria Genetica y Biotecnologia
31 Dec 2009
Whooping Cough
Cuba
Centro de Ingenieria Genetica y Biotecnologia
31 Dec 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free